A Study of Tirzepatide in Participants With Impaired Liver Function
Status:
Completed
Trial end date:
2020-09-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess how fast tirzepatide gets into the blood stream and
how long it takes the body to remove it in participants with impaired liver function compared
to healthy participants. The study will last about two months and will include five visits to
the study center.